title: Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens.
authors.forename: J
authors.initials: J
authors.lastname: Larghero
authors.forename: F
authors.initials: F
authors.lastname: Zassadowski
authors.forename: P
authors.initials: P
authors.lastname: Rousselot
authors.forename: R A
authors.initials: RA
authors.lastname: Padua
authors.forename: L
authors.initials: L
authors.lastname: Degos
authors.forename: C
authors.initials: C
authors.lastname: Chomienne
mesh_terms: D015972:Gene Expression Regulation, Neoplastic; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000235:genetics* / Q000276:immunology*; D009363:Neoplasm Proteins / Q000235:genetics*; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D000090063:Proto-Oncogene Mas; D014157:Transcription Factors / Q000235:genetics*; D025521:Tumor Suppressor Proteins
chemical_list: D015395:Histocompatibility Antigens Class I; C000715470:MAS1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000071156:Promyelocytic Leukemia Protein; D000090063:Proto-Oncogene Mas; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C070576:PML protein, human